• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library
    Generics

    MSN Labs Launches SEMABEST Semaglutide in India After CDSCO Nod

    EXPRESSPHARMA

    MSN Labs Expands Metabolic Care In India With CDSCO Approval

    PHARMABIZ

    SEC Recommends Three Firms For Semaglutide Formulations

    PHARMABIZ

    Novartis Asks Court for Swift Decision in Entresto Patent Case

    FIERCE PHARMA

    Pharma Companies Rush to Develop Weight-loss Drug Semaglutide

    ECONOMICTIMES

    BeiGene defends Brukinsa from MSN`s generic threat until 2037

    FIERCE PHARMA

    Judge upholds MSN`s generic Entresto nod amid Novartis challenge

    FIERCE PHARMA

    Novartis loses latest bid to block generic version of blockbuster heart drug

    REUTERS

    AbbVie puts up fight against Orilissa generics from Sandoz, Teva and others

    ENDPTS

    Novartis files another Entresto patent suit to fight generics

    FIERCEPHARMA

    MSN to launch generic anti-COVID pill Molnupiravir under `Molulow` brand

    ECONOMICTIMES

    Novadoz FDA Approvals of Oseltamivir & Dofetilide Continues the Company`s Rise

    PRNEWSWIRE

    MSN Labs subsidiary, Novadoz Pharma gets US FDA approval for generic Uloric

    PHARMABIZ

    MSN labs to launch two new generics in USA

    THEPHARMALETTER

    FDA greenlights nine Lyrica generics

    IN-PHARMATECHNOLOGIST

    Gilenya (Fingolimod): Novartis Pharmaceuticals Corporation v. Accord Healthcare Inc. et al

    PATENT LITIGATION

    Uloric® (Febuxostat): Teijin Limited et al v. MSN Laboratories Private

    PATENT LITIGATION

    Trintellix® (Vortioxetine HCL) : H. Lundbeck A/S v. MSN Laboratories

    PATENT LITIGATION

    Hetlioz®(Tasimelteon): Vanda Pharmaceuticals v. MSN Pharmaceuticals Inc

    PATENT LITIGATION

    Tecfidera®(Dimethyl Fumarate): Biogen International Gmbh V. MSN Laboratories

    PATENT LITIGATION

    Zytiga® (Abiraterone Acetate): Btg International Limited v. MSN Pharmaceuticals

    PATENT LITIGATION

    Adempas®(Riociguat Tablets): Adverio Pharma Gmbh V. Msn Laboratories Private

    PATENT LITIGATION

    Emend®(Fosaprepitant Dimeglumine): Merck Sharp & Dohme Corp. V. MSN Laboratories

    PATENT LITIGATION

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.